Page last updated: 2024-11-05

zonisamide and Absence of Brain, Congenital

zonisamide has been researched along with Absence of Brain, Congenital in 1 studies

Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.

Research Excerpts

ExcerptRelevanceReference
"Anencephaly was detected in one case at 16 weeks of gestation (case 1, artificial abortion), and atrial septal defect was detected in another case at 37 weeks of gestation (case 2, delivery by cesarean section)."5.29Preliminary report on teratogenic effects of zonisamide in the offspring of treated women with epilepsy. ( Amano, Y; Egawa, I; Kaneko, S; Kondo, T, 1996)
"Anencephaly was detected in one case at 16 weeks of gestation (case 1, artificial abortion), and atrial septal defect was detected in another case at 37 weeks of gestation (case 2, delivery by cesarean section)."1.29Preliminary report on teratogenic effects of zonisamide in the offspring of treated women with epilepsy. ( Amano, Y; Egawa, I; Kaneko, S; Kondo, T, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kondo, T1
Kaneko, S1
Amano, Y1
Egawa, I1

Other Studies

1 other study available for zonisamide and Absence of Brain, Congenital

ArticleYear
Preliminary report on teratogenic effects of zonisamide in the offspring of treated women with epilepsy.
    Epilepsia, 1996, Volume: 37, Issue:12

    Topics: Abnormalities, Drug-Induced; Adult; Anencephaly; Anticonvulsants; Epilepsy; Female; Humans; Infant,

1996